Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Frederic Colombel

Showing results (361-370 of 463) with videos related to

Pageof 47
Sort By:
Environment & Health (Washington, D.C.)|October 30, 2024
Association between Exposure to Metals during Pregnancy, Childhood Gut Microbiome, and Risk of Intestinal Inflammation in Late ChildhoodVishal Midya, Manasi Agrawal, Jamil M Lane, et al.
Lancet (London, England)|August 2, 2016
Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trialJulián Panés, Damián García-Olmo, Gert Van Assche, et al.
Journal of Crohn'S & Colitis|June 27, 2024
Lemann Index for assessing bowel damage in Crohn's disease: a real world studyEric Prado, Cindy C Y Law, Catherine Rowan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 20, 2024
Safety of Immunosuppression in a Prospective Cohort of Inflammatory Bowel Disease Patients With a HIstoRy of CancEr: SAPPHIRE RegistrySteven H Itzkowitz, Yue Jiang, Cristina Villagra, et al.
Inflammatory Bowel Diseases|January 15, 2022
The Multiple Waves of COVID-19 in Patients With Inflammatory Bowel Disease: A Temporal Trend AnalysisGilaad G Kaplan, Fox E Underwood, Stephanie Coward, et al.
Gut|February 17, 2025
Reparative immunological consequences of stem cell transplantation as a cellular therapy for refractory Crohn's diseaseDaniela Guisado, Sayali Talware, Xiaoli Wang, et al.
Journal of Crohn'S & Colitis|November 20, 2025
Benefit-Risk Profile of Upadacitinib: Exploratory Post Hoc Analysis of Phase 2b/3 Studies in Patients With Moderately to Severely Active Ulcerative Colitis or Crohn's DiseaseSeverine Vermeire, Jean-Frederic Colombel, Silvio Danese, et al.
The Lancet. Gastroenterology & Hepatology|April 29, 2022
Lifestyle, behaviour, and environmental modification for the management of patients with inflammatory bowel diseases: an International Organization for Study of Inflammatory Bowel Diseases consensusAshwin N Ananthakrishnan, Gilaad G Kaplan, Charles N Bernstein, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2024
The reparative immunologic consequences of stem cell transplantation as a cellular therapy for refractory Crohn's diseaseDaniela Guisado, Sayali Talware, Xiaoli Wang, et al.
Gastroenterology|May 20, 2020
Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International RegistryErica J Brenner, Ryan C Ungaro, Richard B Gearry, et al.
Pageof 47

Showing results (361-370 of 463) with videos related to

Sort By:
Pageof 47
Environment & Health (Washington, D.C.)|October 30, 2024
Association between Exposure to Metals during Pregnancy, Childhood Gut Microbiome, and Risk of Intestinal Inflammation in Late ChildhoodVishal Midya, Manasi Agrawal, Jamil M Lane, et al.
Lancet (London, England)|August 2, 2016
Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trialJulián Panés, Damián García-Olmo, Gert Van Assche, et al.
Journal of Crohn'S & Colitis|June 27, 2024
Lemann Index for assessing bowel damage in Crohn's disease: a real world studyEric Prado, Cindy C Y Law, Catherine Rowan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 20, 2024
Safety of Immunosuppression in a Prospective Cohort of Inflammatory Bowel Disease Patients With a HIstoRy of CancEr: SAPPHIRE RegistrySteven H Itzkowitz, Yue Jiang, Cristina Villagra, et al.
Inflammatory Bowel Diseases|January 15, 2022
The Multiple Waves of COVID-19 in Patients With Inflammatory Bowel Disease: A Temporal Trend AnalysisGilaad G Kaplan, Fox E Underwood, Stephanie Coward, et al.
Gut|February 17, 2025
Reparative immunological consequences of stem cell transplantation as a cellular therapy for refractory Crohn's diseaseDaniela Guisado, Sayali Talware, Xiaoli Wang, et al.
Journal of Crohn'S & Colitis|November 20, 2025
Benefit-Risk Profile of Upadacitinib: Exploratory Post Hoc Analysis of Phase 2b/3 Studies in Patients With Moderately to Severely Active Ulcerative Colitis or Crohn's DiseaseSeverine Vermeire, Jean-Frederic Colombel, Silvio Danese, et al.
The Lancet. Gastroenterology & Hepatology|April 29, 2022
Lifestyle, behaviour, and environmental modification for the management of patients with inflammatory bowel diseases: an International Organization for Study of Inflammatory Bowel Diseases consensusAshwin N Ananthakrishnan, Gilaad G Kaplan, Charles N Bernstein, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2024
The reparative immunologic consequences of stem cell transplantation as a cellular therapy for refractory Crohn's diseaseDaniela Guisado, Sayali Talware, Xiaoli Wang, et al.
Gastroenterology|May 20, 2020
Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International RegistryErica J Brenner, Ryan C Ungaro, Richard B Gearry, et al.
Pageof 47